Amgen v Sanofi: Big Pharma awaits SCOTUS decision

The Supreme Court recently granted a petition for a writ of certiorari in a case concerning an issue of significant importance in the pharmaceutical and chemical technology industry.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Don’t distort enablement law, Amgen tells SCOTUS

9 March 2023 Sanofi and Regeneron accused of wanting to change patent system | The US Supreme Court will decide whether a controversial court decision should stand.

Big Pharma

Sanofi backed by big pharma and more in SCOTUS clash

Big Pharma

Amgen asks Fed Circ to rehear $1.1bn Juno patent suit

16 November 2021 Amgen and two research centres have thrown their support behind Bristol Myers Squibb subsidiary Juno Therapeutics to help restore a $1.1 billion patent judgment against Kite Pharma that was overturned by the US Court of Appeals for the Federal Circuit.

More on this story

Big Pharma

Don’t distort enablement law, Amgen tells SCOTUS

9 March 2023 Sanofi and Regeneron accused of wanting to change patent system | The US Supreme Court will decide whether a controversial court decision should stand.

Big Pharma

Sanofi backed by big pharma and more in SCOTUS clash

Big Pharma

Amgen asks Fed Circ to rehear $1.1bn Juno patent suit

More on this story

Big Pharma

Don’t distort enablement law, Amgen tells SCOTUS

9 March 2023 Sanofi and Regeneron accused of wanting to change patent system | The US Supreme Court will decide whether a controversial court decision should stand.

Big Pharma

Sanofi backed by big pharma and more in SCOTUS clash

Big Pharma

Amgen asks Fed Circ to rehear $1.1bn Juno patent suit